HALOPERIDOL vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Clinical response to treatment · patients with schizophrenia
HALOPERIDOL showed no clear difference in clinical response to treatment compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (low certainty).
1 finding from 1 review
- Haloperidol versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 1.11 [0.86, 1.44]14 studies · 574 participantsLow